Lupus Erythematosus

<p>Introduction</p><p>      EM Massarotti and PH Schur</p><p> </p><p>1. SLE Epidemiology: Epidemiology Subtypes and Risk Factors for Development</p><p>      JF Simard,  and KH Costenbader</p><p> </p><p>2. The Immunopathogenesis and Immunopathology of SLE</p><p>        D Pisetsky</p><p> </p><p>3. Diagnosis and Monitoring SLE</p><p>      PH Schur</p><p> </p><p>4. Clinical Monitoring of the Patient with Lupus</p><p>             VP Bykerk</p><p> </p><p>5. The Treatment of SLE: General Principles</p><p>       EM Massarotti and PH Schur</p><p> </p><p>6. Cutaneous Manifestations of Lupus Erythematosus</p><p>       H Townsend, and  RA Vleugels</p><p> </p><p>7. Musculoskeletal Manifestations of SLE</p><p>       S Helfgott</p><p> </p><p>8. The Cerebrovascular System in SLE</p><p>      R Sands</p><p> </p><p>9. Pulmonary Manifestations of SLE</p><p>      HJ Goldberg, and PF Dellaripa</p><p> </p><p>10. Hematologic Manifestations of SLE</p><p>        N Berliner</p><p> </p><p>11. Renal Manifestations of SLE</p><p>      M Dooley</p><p> </p><p>12. Gastrointestinal Manifestations of SLE</p><p>       RS Kalman and J Wolf</p><p> </p><p>13. Neuropsychiatric Aspects of SLE</p><p>       S Khoshbin</p><p> </p><p>14. SLE and Pregnancy</p><p>    B Bermas</p><p> </p><p>15. Anti-phospholipid Antibody Syndrome</p><p>    B Bermas</p><p> </p><p>16. Lupus-Like Syndromes related to Drugs</p><p>        J Merola</p><p> </p><p>17. New and Emerging Therapies for SLE</p><p>     EM Massarotti</p><p> </p><p>18. Comorbidities in SLE</p>       M Gayed, C-S Yee, S Bernatsky, C Gordon